Filomena Boccia
-
- COVID-19 Clinical Research Studies 4
- Antimicrobial Resistance in Staphylococcus 2
- SARS-CoV-2 and COVID-19 Research 1
-
- Bacterial Identification and Susceptibility Testing 1
-
- Infective Endocarditis Diagnosis and Management 2
- Urinary Tract Infections Management 1
-
- Venous Thromboembolism Diagnosis and Management 2
-
- Long-Term Effects of COVID-19 2
- Co-authors
- Rosa ZampinoEmanuele Durante‐MangoniArta KarruliRoberto AndiniMaria Paola UrsiMassimo GagliardiFabian PataunerRosanna Carmela De Rosa
- Journals
- SHILAP Revista de lepidopterología (1 paper)Journal of Clinical Medicine (2 papers)Journal of NeuroVirology (1 paper)
- Partner nations
- ItalyGreeceUnited Kingdom
In The Last Decade
Filomena Boccia
8 papers receiving 81 citations
Peers
Comparison fields: 5 of 26
- Applied Microbiology and Biotechnology 37
- Molecular Medicine 29
- Infectious Diseases 45
- Critical Care and Intensive Care Medicine 11
- Clinical Biochemistry 8
Countries citing papers authored by Filomena Boccia
This map shows the geographic impact of Filomena Boccia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filomena Boccia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filomena Boccia more than expected).
Fields of papers citing papers by Filomena Boccia
This network shows the impact of papers produced by Filomena Boccia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filomena Boccia. The network helps show where Filomena Boccia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Filomena Boccia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 0 | |
| 6 | 2021 | 13 | |
| 7 | 2021 | 47 | |
| 8 | 2021 | 0 | |
| 9 | 2021 | 3 | |
| 10 | 2020 | 13 |
About Filomena Boccia
Filomena Boccia is a scholar working on Internal Medicine, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 10 papers that have together received 81 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), Infective Endocarditis Diagnosis and Management (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Long-Term Effects of COVID-19 (2 papers), Urinary Tract Infections Management (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Bacterial Identification and Susceptibility Testing (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (37 citations), Molecular Medicine (29 citations) and Infectious Diseases (45 citations). Filomena Boccia has collaborated with scholars based in Italy, Greece and United Kingdom. Frequent co-authors include Rosa Zampino, Emanuele Durante‐Mangoni, Arta Karruli, Roberto Andini, Maria Paola Ursi, Massimo Gagliardi, Fabian Patauner, Rosanna Carmela De Rosa, Giuseppe Ruocco and Patrizia Murino. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Clinical Medicine and Journal of NeuroVirology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.